Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over
Donna H. Ryan, Sarah R. Yockey
Current Obesity Reports (2017) Vol. 6, Iss. 2, pp. 187-194
Open Access | Times Cited: 595

Showing 1-25 of 595 citing articles:

Tirzepatide Once Weekly for the Treatment of Obesity
Ania M. Jastreboff, Louis J. Aronne, Nadia N. Ahmad, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 3, pp. 205-216
Open Access | Times Cited: 1714
Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial
Juan P. Frías, Michael A. Nauck, Joanna Van, et al.
The Lancet (2018) Vol. 392, Iss. 10160, pp. 2180-2193
Closed Access | Times Cited: 658
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity
Thomas A. Wadden, Timothy S. Bailey, Liana K. Billings, et al.
JAMA (2021) Vol. 325, Iss. 14, pp. 1403-1403
Open Access | Times Cited: 623
Effects of 8-hour time restricted feeding on body weight and metabolic disease risk factors in obese adults: A pilot study
Kelsey Gabel, Kristin K. Hoddy, Nicole Haggerty, et al.
Nutrition and Healthy Aging (2018) Vol. 4, Iss. 4, pp. 345-353
Open Access | Times Cited: 527
Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures – 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists
Jeffrey I. Mechanick, Caroline M. Apovian, Stacy A. Brethauer, et al.
Surgery for Obesity and Related Diseases (2019) Vol. 16, Iss. 2, pp. 175-247
Closed Access | Times Cited: 413
Clinical Practice Guidelines For The Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures – 2019 Update: Cosponsored By American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society For Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists
Jeffrey I. Mechanick, Caroline M. Apovian, Stacy A. Brethauer, et al.
Endocrine Practice (2019) Vol. 25, pp. 1-75
Open Access | Times Cited: 398
Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures – 2019 Update: Cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists
Jeffrey I. Mechanick, Caroline M. Apovian, Stacy A. Brethauer, et al.
Obesity (2020) Vol. 28, Iss. 4
Closed Access | Times Cited: 242
Obesity Management in Adults
Arielle Elmaleh-Sachs, Jessica L. Schwartz, Carolyn T. Bramante, et al.
JAMA (2023) Vol. 330, Iss. 20, pp. 2000-2000
Open Access | Times Cited: 226
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial
Lone B Enebo, Kasper K. Berthelsen, Martin Kankam, et al.
The Lancet (2021) Vol. 397, Iss. 10286, pp. 1736-1748
Closed Access | Times Cited: 221
AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity
Eduardo Grunvald, Raj Shah, Rubén Hernáez, et al.
Gastroenterology (2022) Vol. 163, Iss. 5, pp. 1198-1225
Open Access | Times Cited: 135
Anti-diabetic drugs and weight loss in patients with type 2 diabetes
Elisa Lazzaroni, Moufida Ben Nasr, Cristian Loretelli, et al.
Pharmacological Research (2021) Vol. 171, pp. 105782-105782
Open Access | Times Cited: 121
Semaglutide for the treatment of overweight and obesity: A review
Natasha C. Bergmann, Melanie J. Davies, Ildiko Lingvay, et al.
Diabetes Obesity and Metabolism (2022) Vol. 25, Iss. 1, pp. 18-35
Open Access | Times Cited: 109
Excess body weight: Novel insights into its roles in obesity comorbidities
Xiang Zhang, Suki Ha, Harry Cheuk-Hay Lau, et al.
Seminars in Cancer Biology (2023) Vol. 92, pp. 16-27
Open Access | Times Cited: 107
Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial
Donna H. Ryan, Ildiko Lingvay, John Deanfield, et al.
Nature Medicine (2024) Vol. 30, Iss. 7, pp. 2049-2057
Open Access | Times Cited: 80
Obesity in South and Southeast Asia—A new consensus on care and management
Kwang Wei Tham, Rohana Abdul Ghani, C. Sioksoan, et al.
Obesity Reviews (2022) Vol. 24, Iss. 2
Open Access | Times Cited: 78
Changing the global obesity narrative to recognize and reduce weight stigma: A position statement from the World Obesity Federation
Sarah Nutter, Laura Ann Eggerichs, Taniya S. Nagpal, et al.
Obesity Reviews (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 77
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
Juan P. Frías, Stanley H. Hsia, Sarah Eyde, et al.
The Lancet (2023) Vol. 402, Iss. 10400, pp. 472-483
Closed Access | Times Cited: 71
Patient-Centered Care for Obesity: How Health Care Providers Can Treat Obesity While Actively Addressing Weight Stigma and Eating Disorder Risk
Michelle I. Cardel, Faith A. Newsome, Rebecca L. Pearl, et al.
Journal of the Academy of Nutrition and Dietetics (2022) Vol. 122, Iss. 6, pp. 1089-1098
Open Access | Times Cited: 70
Adolescent PCOS: a postpubertal central obesity syndrome
Lourdes Ibáñez, Francis de Zegher
Trends in Molecular Medicine (2023) Vol. 29, Iss. 5, pp. 354-363
Open Access | Times Cited: 51
Treatable Traits in Airway Disease: From Theory to Practice
Àlvar Agustí, Peter G. Gibson, Vanessa M. McDonald
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 3, pp. 713-723
Open Access | Times Cited: 44
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024
Harold Bays, Carol F. Kirkpatrick, Kevin C. Maki, et al.
Journal of clinical lipidology (2024) Vol. 18, Iss. 3, pp. e320-e350
Open Access | Times Cited: 25
Tirzepatide for Weight Reduction in Chinese Adults With Obesity
Lin Zhao, Zhifeng Cheng, Yibing Lu, et al.
JAMA (2024)
Open Access | Times Cited: 25
Pharmacotherapy for obesity: moving towards efficacy improvement
Walmir Coutinho, Bruno Halpern
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 20
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024
Harold Bays, Carol F. Kirkpatrick, Kevin C. Maki, et al.
Obesity Pillars (2024) Vol. 10, pp. 100108-100108
Open Access | Times Cited: 19
Obesity
Adam H. Gilden, Victoria A. Catenacci, John Michael Taormina
Annals of Internal Medicine (2024) Vol. 177, Iss. 5, pp. ITC65-ITC80
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top